{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:34:40Z","timestamp":1794472480066,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Program of Hunan Province","award":["2023SK2022"],"award-info":[{"award-number":["2023SK2022"]}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2024JJ5575"],"award-info":[{"award-number":["2024JJ5575"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Changsha, China","award":["kq2403031"],"award-info":[{"award-number":["kq2403031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04256-x","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:07:04Z","timestamp":1773673624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["tLyP-1 peptide-modified MnO\u2082 co-delivering si-SLC16A1 and temozolomide synergistically suppresses glioblastoma via hypoxia modulation and metabolic stress"],"prefix":"10.1186","volume":"24","author":[{"given":"Haiting","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"4256_CR1","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, et al. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780.","journal-title":"Pharmacol Res"},{"key":"4256_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semcancer.2019.10.010","volume":"60","author":"TT Lah","year":"2020","unstructured":"Lah TT, Novak M, Breznik B. Brain malignancies: Glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262\u201373.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4256_CR3","first-page":"54","volume":"4","author":"D Khosla","year":"2016","unstructured":"Khosla D. Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann Transl Med. 2016;4(3):54.","journal-title":"Ann Transl Med"},{"issue":"1","key":"4256_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-014-1368-7","volume":"117","author":"MG McNamara","year":"2014","unstructured":"McNamara MG, et al. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era. J Neurooncol. 2014;117(1):153\u201360.","journal-title":"J Neurooncol"},{"key":"4256_CR5","doi-asserted-by":"crossref","unstructured":"Ter Linden E et al. Overcoming barriers in glioblastoma-advances in drug delivery strategies. Cells 2024;13(12):998.","DOI":"10.3390\/cells13120998"},{"issue":"1","key":"4256_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41540-020-00161-7","volume":"7","author":"SRC Immanuel","year":"2021","unstructured":"Immanuel SRC, et al. Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells. NPJ Syst Biol Appl. 2021;7(1):2.","journal-title":"NPJ Syst Biol Appl"},{"issue":"7","key":"4256_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, et al. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18(7):452\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4256_CR8","doi-asserted-by":"publisher","first-page":"e1720","DOI":"10.1002\/wnan.1720","volume":"13","author":"G Yang","year":"2021","unstructured":"Yang G, Ji J, Liu Z. Multifunctional MnO(2) nanoparticles for tumor microenvironment modulation and cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(6):e1720.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4256_CR9","doi-asserted-by":"crossref","unstructured":"Park JH, Lee HK. Current understanding of hypoxia in glioblastoma multiforme and its response to immunotherapy. Cancers (Basel) 2022;14(5):35267480.","DOI":"10.3390\/cancers14051176"},{"issue":"1","key":"4256_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Therapy. 2023;8(1):70.","journal-title":"Signal Transduct Target Therapy"},{"key":"4256_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jcis.2024.07.121","volume":"676","author":"J Yuan","year":"2024","unstructured":"Yuan J, et al. Brain-targeting biomimetic disguised manganese dioxide nanoparticles via hybridization of tumor cell membrane and bacteria vesicles for synergistic chemotherapy\/chemodynamic therapy of glioma. J Colloid Interface Sci. 2024;676:378\u201395.","journal-title":"J Colloid Interface Sci"},{"key":"4256_CR12","doi-asserted-by":"publisher","first-page":"100927","DOI":"10.1016\/j.blre.2022.100927","volume":"54","author":"NB Charbe","year":"2022","unstructured":"Charbe NB, et al. A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers. Blood Rev. 2022;54:100927.","journal-title":"Blood Rev"},{"key":"4256_CR13","doi-asserted-by":"publisher","first-page":"114833","DOI":"10.1016\/j.biopha.2023.114833","volume":"163","author":"S Sisakhtnezhad","year":"2023","unstructured":"Sisakhtnezhad S, Rahimi M, Mohammadi S. Biomedical applications of MnO(2) nanomaterials as nanozyme-based theranostics. Biomed Pharmacother. 2023;163:114833.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4256_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/nano.202100040","volume":"2","author":"T Munjal","year":"2021","unstructured":"Munjal T, Dutta S. Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics. Nano Select. 2021;2(10):1849\u201373.","journal-title":"Nano Select"},{"issue":"4","key":"4256_CR15","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/nn405773r","volume":"8","author":"P Prasad","year":"2014","unstructured":"Prasad P, et al. Multifunctional albumin-MnO(2) nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8(4):3202\u201312.","journal-title":"ACS Nano"},{"issue":"6","key":"4256_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.7150\/thno.22989","volume":"8","author":"D Hu","year":"2018","unstructured":"Hu D, et al. Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy. Theranostics. 2018;8(6):1558\u201374.","journal-title":"Theranostics"},{"key":"4256_CR17","doi-asserted-by":"crossref","unstructured":"Fan M et al. Cu-Mn nanocomposite for enhanced tumor cuproptosis achieved by remodeling the tumor microenvironment and activating the antitumor immunogenic responses. Acta Biomater. 2025;194:385\u201395.","DOI":"10.1016\/j.actbio.2025.01.044"},{"issue":"1","key":"4256_CR18","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1038\/s41467-019-10566-6","volume":"10","author":"PD Bosshart","year":"2019","unstructured":"Bosshart PD, et al. Mechanistic basis of L-lactate transport in the SLC16 solute carrier family. Nat Commun. 2019;10(1):2649.","journal-title":"Nat Commun"},{"issue":"12","key":"4256_CR19","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.7150\/jca.95258","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang J, et al. Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma. J Cancer. 2024;15(12):3794\u2013808.","journal-title":"J Cancer"},{"key":"4256_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1479-5876-12-118","volume":"12","author":"C Pinheiro","year":"2014","unstructured":"Pinheiro C, et al. Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization. J Transl Med. 2014;12:118.","journal-title":"J Transl Med"},{"issue":"20","key":"4256_CR21","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-17-0764","volume":"77","author":"VL Payen","year":"2017","unstructured":"Payen VL, et al. Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter. Cancer Res. 2017;77(20):5591\u2013601.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"4256_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10555-019-09792-7","volume":"38","author":"SR Pillai","year":"2019","unstructured":"Pillai SR, et al. Causes, consequences, and therapy of tumors acidosis. Cancer Metastasis Rev. 2019;38(1\u20132):205\u201322.","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"4256_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s12031-021-01806-w","volume":"71","author":"HH Lin","year":"2021","unstructured":"Lin HH, et al. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas. J Mol Neurosci. 2021;71(8):1614\u201321.","journal-title":"J Mol Neurosci"},{"key":"4256_CR24","doi-asserted-by":"publisher","first-page":"106200","DOI":"10.1016\/j.bioorg.2022.106200","volume":"130","author":"L Larue","year":"2023","unstructured":"Larue L, et al. tLyp-1: A peptide suitable to target NRP-1 receptor. Bioorg Chem. 2023;130:106200.","journal-title":"Bioorg Chem"},{"key":"4256_CR25","doi-asserted-by":"publisher","first-page":"123852","DOI":"10.1016\/j.ijpharm.2024.123852","volume":"652","author":"BA Zhaisanbayeva","year":"2024","unstructured":"Zhaisanbayeva BA, et al. In vitro and in vivo toxicity of thiolated and PEGylated organosilica nanoparticles. Int J Pharm. 2024;652:123852.","journal-title":"Int J Pharm"},{"key":"4256_CR26","doi-asserted-by":"publisher","first-page":"123100","DOI":"10.1016\/j.biomaterials.2025.123100","volume":"317","author":"J Chen","year":"2025","unstructured":"Chen J, et al. Bioresponsive nanoreactor initiates cascade reactions for tumor vascular normalization and lactate depletion to augment immunotherapy. Biomaterials. 2025;317:123100.","journal-title":"Biomaterials"},{"key":"4256_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020;7:193.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4256_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10517-020-05021-2","volume":"170","author":"IA Razumov","year":"2020","unstructured":"Razumov IA, et al. Manganese Oxide Nanoparticles Inhibit the Growth of Subcutaneous U-87MG Glioblastoma Xenografts in Immunodeficient Mouse. Bull Exp Biol Med. 2020;170(1):148\u201353.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"4256_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12951-024-02531-3","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma. J Nanobiotechnol. 2024;22(1):264.","journal-title":"J Nanobiotechnol"},{"key":"4256_CR30","doi-asserted-by":"crossref","unstructured":"Cortes Ballen AI et al. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cells, 2024. 13(18).","DOI":"10.3390\/cells13181574"},{"key":"4256_CR31","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.2147\/IJN.S477026","volume":"19","author":"L Liang","year":"2024","unstructured":"Liang L, et al. Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy. Int J Nanomed. 2024;19:8883\u2013900.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4256_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acs.molpharmaceut.4c00817","volume":"22","author":"J Ma","year":"2025","unstructured":"Ma J, et al. Oxygen\/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis. Mol Pharm. 2025;22(1):168\u201380.","journal-title":"Mol Pharm"},{"issue":"9","key":"4256_CR33","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123(9):3685\u201392.","journal-title":"J Clin Invest"},{"key":"4256_CR34","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, et al. Lactate in the tumour microenvironment: From immune modulation to therapy. EBioMedicine. 2021;73:103627.","journal-title":"EBioMedicine"},{"key":"4256_CR35","doi-asserted-by":"crossref","unstructured":"Keller CR et al. Lactate oxidase disrupts lactate-activated ras and pi3k oncogenic signaling. Cancers (Basel) 2024;16(16):2817.","DOI":"10.3390\/cancers16162817"},{"issue":"3","key":"4256_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10565-019-09502-7","volume":"36","author":"VS Tomar","year":"2020","unstructured":"Tomar VS, Patil V, Somasundaram K. Temozolomide induces activation of Wnt\/beta-catenin signaling in glioma cells via PI3K\/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020;36(3):273\u20138.","journal-title":"Cell Biol Toxicol"},{"key":"4256_CR37","doi-asserted-by":"crossref","unstructured":"Yalamarty SSK et al. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers (Basel), 2023. 15(7).","DOI":"10.3390\/cancers15072116"},{"key":"4256_CR38","doi-asserted-by":"publisher","first-page":"641469","DOI":"10.3389\/fcell.2021.641469","volume":"9","author":"P Wu","year":"2021","unstructured":"Wu P, et al. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol. 2021;9:641469.","journal-title":"Front Cell Dev Biol"},{"key":"4256_CR39","first-page":"50","volume":"29","author":"X Xu","year":"2023","unstructured":"Xu X, et al. Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics. Bioact Mater. 2023;29:50\u201371.","journal-title":"Bioact Mater"},{"issue":"1","key":"4256_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.200208089","volume":"160","author":"JE Ricci","year":"2003","unstructured":"Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol. 2003;160(1):65\u201375.","journal-title":"J Cell Biol"},{"issue":"22","key":"4256_CR41","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1016\/j.biomaterials.2013.04.025","volume":"34","author":"Q Hu","year":"2013","unstructured":"Hu Q, et al. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Biomaterials. 2013;34(22):5640\u201350.","journal-title":"Biomaterials"},{"issue":"1","key":"4256_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1021\/mp400189j","volume":"11","author":"D Miao","year":"2014","unstructured":"Miao D, et al. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Mol Pharm. 2014;11(1):90\u2013101.","journal-title":"Mol Pharm"},{"key":"4256_CR43","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.2147\/IJN.S218085","volume":"14","author":"X Cai","year":"2019","unstructured":"Cai X, et al. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy. Int J Nanomed. 2019;14:8321\u201344.","journal-title":"Int J Nanomed"},{"key":"4256_CR44","doi-asserted-by":"publisher","first-page":"1484577","DOI":"10.3389\/fbioe.2024.1484577","volume":"12","author":"W Wang","year":"2024","unstructured":"Wang W, et al. Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging. Front Bioeng Biotechnol. 2024;12:1484577.","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04256-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T22:59:51Z","timestamp":1779663591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04256-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The guidelines for the care and use of animals were approved by the Animal Ethics Committee of Xiangya Hospital (Approval No.: 202316550).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}